WaferGen Bio-systems, Inc. 4
4 · WaferGen Bio-systems, Inc. · Filed Mar 1, 2017
Insider Transaction Report
Form 4
Schueren Robert Alan
Director
Transactions
- Disposition to Issuer
Common Stock
2017-02-28$7.35/sh−8,368$61,481→ 0 total(indirect: See Footnote)
Footnotes (3)
- [F1]Includes 3,049 restricted stock units ("RSUs").
- [F2]Pursuant to the Agreement and Plan of Merger, dated May 12, 2016, by and among WaferGen Bio-systems, Inc., Takara Bio USA Holdings, Inc., Walrus Acquisition Corporation and Takara Bio USA, Inc., (i) each issued and outstanding RSU was automatically vested and converted into the right to receive $7.347126 in cash, without interest, and (ii) each issued and outstanding share of common stock was automatically cancelled and converted into the right to receive $7.347126 in cash, without interest.
- [F3]All shares were held by Montclaire Partners ("Montclaire") and all RSUs were held by the reporting person as nominee and for the benefit of Montclaire.